Chemometrics approach for the prediction of structure–activity relationship for membrane transporter bilitranslocaseFootnote

£ Presented at the 16th International Workshop on Quantitative Structure–Activity Relationships in Environmental and Health Sciences (QSAR2014), 16–20 June 2014, Milan, Italy.

References

• D.B. Kell, P.D. Dobson, and S.G. Oliver, Pharmaceutical drug transport: The issues and the implications that it is essentially carrier-mediated only, Drug Discov. 16 (2011), pp. 704–714.
   Google Scholar
• P.D. Dobson, K. Lanthaler, S.G. Oliver, and D.B. Kell, Implications of the dominant role of transporters in drug uptake by cells, Curr. Top. Med. Chem. 9 (2009), pp. 163–181.
   PubMed Web of Science ®Google Scholar
• D.B. Kell and P.D. Dobson, The cellular uptake of pharmaceutical drugs is mainly carrier-mediated and is thus an issue not so much of biophysics but of systems biology, Syst. Chem. (2008), pp. 149–168.
   Google Scholar
• P.D. Dobson and D.B. Kell, Carrier-mediated cellular uptake of pharmaceutical drugs: An exception or the rule?, Nat. Rev. Drug Discov. 7 (2008), pp. 205–220.
   PubMed Web of Science ®Google Scholar
• N. Mizuno, T. Niwa, Y. Yotsumoto, and Y. Sugiyama, Impact of drug transporter studies on drug discovery and development, Pharm. Rev. 55 (2003), pp. 425–461.
   PubMed Web of Science ®Google Scholar
• S. Passamonti, U. Vrhovsek, and F. Mattivi, The interaction of anthocyanins with bilitranslocase, Biochem. Biophys. Res. Commun. 296 (2002), pp. 631–636.
   PubMed Web of Science ®Google Scholar
• S. Passamonti, M. Terdoslavich, N. Medic, A. Margon, A. Cocolo, F. Micalli, G. Decorti, and M. Franko, Uptake of bilirubin into HepG2 cells assayed by thermal lens spectroscopy, Function of bilitranslocase, FEBS J. 272 (2005), pp. 5522–5535.
   PubMed Web of Science ®Google Scholar
• S. Passamonti, M. Terdoslavich, R. Franca, A. Vanzo, F. Tramer, E. Braidot, E. Petrussa, and A. Vianello, Bioavailability of flavonoids: A review of their membrane transport and the function of bilitranslocase in animal and plant organisms, Curr. Drug Metab. 10 (2009), pp. 369–394.
   PubMed Web of Science ®Google Scholar
• M. Terdoslavich, Molecular mechanisms of organic anion transport, PhD disseration, University of Trieste, Italy, PhD disseration, 2005.
   Google Scholar
• A. Karawajczyk, V. Drgan, N. Medic, G. Oboh, S. Passamnonti, and M. Novič, Properties of flavonoids influencing the binding to bilitranslocase investigated by neural network modelling, Biochem. Pharm. 73 (2007), pp. 308–320.
   PubMed Web of Science ®Google Scholar
• Š. Župerl, S. Fornasaro, M. Novič, and S. Passamonti, Experimental determination and prediction of bilitranslocase transport activity, Anal. Chim. Acta. 705 (2011), pp. 322–333.
   PubMed Web of Science ®Google Scholar
• S. Passamonti, U. Vrhovsek, A. Vanzo, and F. Mattivi, The stomach as a site for anthocyanins absorption from food, FEBS Lett. 544 (2003), pp. 210–213.
   PubMed Web of Science ®Google Scholar
• A. Maestro, M. Terdoslavich, A. Vanzo, A. Kuku, F. Tramer, V. Nicolin, F. Micalli, G. Decorti, and S. Passamonti, Expression of bilitranslocase in the vascular endothelium and its function as a flavonoid transporter, Cardiovasc. Res. 85 (2010), pp. 175–183.
   PubMed Web of Science ®Google Scholar
• M. Terdoslavich, I.A. de Graaf, J.H. Proost, A. Cocolo, S. Passamonti, and G.M. Groothuis, Bilitranslocase is involved in the uptake of bromosulfophthalein in rat and human liver, Drug Metab. Lett. 6 (2012), pp. 165–173.
   PubMedGoogle Scholar
• I. Huber-Ruano and M. Pastor-Anglada, Transport of nucleoside analogs across the plasma membrane: A clue to understanding drug-induced cytotoxicity, Curr. Drug Metab. 10 (2009), pp. 347–58.
   PubMed Web of Science ®Google Scholar
• J.D. Young, S.Y.M. Yao, J.M. Baldwin, C.E. Cass, and S.A. Baldwin, The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29, Mol. Aspects. Med. 34 (2013), pp. 529–547.
   PubMed Web of Science ®Google Scholar
• J.H. Gray, R.P. Owen, and K.M. Giacomini, The concentrative nucleoside transporter family, SLC28, Pflugers Arch. 447 (2004), pp. 728–734.
   PubMed Web of Science ®Google Scholar
• S.A. Baldwin, P.R. Beal, S.Y. Yao, A.E. King, C.E. Cass, and J.D. Young, The equilibrative nucleoside transporter family, SLC29, Pflugers Arch. 447 (2004), pp. 735–743.
   PubMed Web of Science ®Google Scholar
• H.S. Milton, V.S. Jr. Reddy, D.G. Tamang, and A. Västermark, The transporter classification database, Nucleic Acids Res. 42 (2014), pp. 251–258; database available at http://www.tcdb.org.
   Google Scholar
• A. Roy, Choudhury and M. Novič, Data-driven model for the prediction of protein transmembrane regions, SAR QSAR Environ. Res. 20 (2009), pp. 741–754.
   PubMed Web of Science ®Google Scholar
• A. Roy Choudhury, Development of transmembrane region prediction algorithms and structural elucidation of bilitranslocase, PhD dissertation, Jožef Stefan International Postgraduate School, Ljubljana, Slovenia, 2013.
   Google Scholar
• A. Perdih, A. Roy Choudhury, Š. Župerl, E. Sikorska, I. Zhukov, T. Solmajer, and M. Novič, Structural analysis of a peptide fragment of transmembrane transporter protein bilitranslocase, PLoS One 7 (2012), p. e38967.
   PubMed Web of Science ®Google Scholar
• A. Roy Choudhury, A. Perdih, Š. Župerl, E. Sikorska, T. Solmajer, S. Jurga, and I. Zhukov, M. Novič, Structural elucidation of transmembrane transporter protein bilitranslocase: Conformational analysis of the second transmembrane region TM2 by molecular dynamics and NMR spectroscopy, Biochim. Biophys. Acta. 1828 (2013), pp. 2609–2619.
   PubMed Web of Science ®Google Scholar
• A. Cherkasov, E.N. Muratov, D. Fourches, A. Varnek, I.I. Baskin, M. Cronin, J. Dearden, P. Gramatica, Y.C. Martin, R. Todeschini, and V. Consonni, V.E. Kuz’min, R. Cramer, R. Benigni, C. Yang, J. Rathman, L. Terfloth, J. Gasteiger, A. Richard, and A. Tropsha, QSAR Modeling: Where have you been? Where are you going to?, J. Med. Chem. 57 (2014), pp. 4977–5010.
   PubMed Web of Science ®Google Scholar
• A. Tropsha, Best practices for QSAR model development, validation, and exploitation, Mol. Inform. 29 (2010), pp. 476–488.
   PubMed Web of Science ®Google Scholar
• A. Tropsha, P. Gramatica, and V.K. Gombar, The importance of being earnest: Validation is the absolute essential for successful application and interpretation of QSPR models, QSAR Comb. Sci. 22 (2003), pp. 69–77.
   Google Scholar
• D. Vidal, R. Garcia-Serna, and J. Mestres, Ligand-based approaches to in silico pharmacology, Methods Mol. Biol. 672 (2011), pp. 489–502.
   PubMedGoogle Scholar
• A. Roy Choudhury, Š. Župerl, and S. Passamonti, M. Novič, Structure elucidation of transmembrane proteins using public-available databases and experimental data on competitive inhibition, Acta Chim. Slov. 58 (2011), pp. 385–392.
   PubMed Web of Science ®Google Scholar
• S.C. Zimmermann, J.M. Sadler, P.I. O’Daniel, N.T. Kim, and K.L. Seley-Radtke, ‘Reverse’ carbocyclic fleximeres: Synthesis of a new class of adenosine deaminase inhibitor, Nucleosides, Nucleotides Nucleic Acids 32 (2013), pp. 137–154.
   PubMed Web of Science ®Google Scholar
• O.R. Wauchope, C. Johnson, P. Krishnamoorthy, G. Andrei, R. Snoeck, J. Balzarini, and K.L. Seley-Radtke, Synthesis and biological evaluation of a series of thieno-expanded tricyclic purine 2′-deoxy nucleoside analogues, J. Bioorg. Med. Chem. 20 (2012), pp. 3009–3015.
   PubMed Web of Science ®Google Scholar
• M.S. Novikov, V.T. Valuev-Ellston, D.A. Babakov, M.P. Paramonova, A.V. Ivanov, S.A. Gavryushov, A.L. Khandazhinskaya, S.N. Kochetkov, C. Pannecouque, G. Andrei, R. Snoeck, J. Balzarini, and K.L. Seley-Radtke, N1, N3-distributed uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase, J. Bioorg. Med. Chem. 21 (2013), pp. 1150–1158.
   PubMed Web of Science ®Google Scholar
• M.M. Dias, N.F.L. Machado, and M.P.M. Marques, Dietary chromones as antioxidant agents – the structural variable, Food Funct. 2 (2011), pp. 595–602.
   PubMed Web of Science ®Google Scholar
• N.F.L. Machado, R. Calheiros, S.M. Fiuza, F. Borges, A. Gaspar, J. Garrido, and M.P. Marques, Phenolic esters with potential anticancer activity – the structural variable, J. Mol. Model. 13 (2007), pp. 865–877.
   PubMed Web of Science ®Google Scholar
• Organsiation for Econmic Co-operation and Development, OECD guidance document on the validation of (quantitative) structure-activity relationship [(Q)SAR] models, ENV/JM/MONO 2, OECD, Paris, 2007.
   Google Scholar
• D. Habrant, S. Poigny, M. Ségur-Derai, Y. Brunel, B. Heurtaux, T. Le Gall, A. Strehle, R. Saladin, S. Meunier, C. Mioskowski, and A. Wagner, Evaluation of antioxidant properties of monoaromatic derivatives of pulvinic acids, J. Med. Chem. 52 (2009), pp. 2454–2464.
   PubMed Web of Science ®Google Scholar
• A. Le Roux, I. Kuzmanovski, D. Habrant, S. Meunier, P. Bischoff, B. Nadal, S.A.L. Thetiot-Laurent, T. Le Gall, A. Wagner, and M. Novič, Design and synthesis of new antioxidants predicted by the model developed on a set of pulvinic acid derivatives, J. Chem. Inf. Model. 51 (2011), pp. 3050–3059.
   PubMed Web of Science ®Google Scholar
• K. Venko, Š. Župerl, and M. Novič, Prediction of antiprion activity of therapeutic agents with structure-activity models, Mol. Divers. 18 (2014), pp. 133–148.
   PubMed Web of Science ®Google Scholar
• G.L. Sottocasa, S. Passamonti, L. Battiston, L. Pascolo, and C. Tiribelli, Molecular aspects of organic anion uptake in liver, J. Hepatol. 24 (1996), pp. 36–41.
   PubMed Web of Science ®Google Scholar
• S. Passamonti and G.L. Sottocasa, The quinoid structure is the molecular requirement for recognition of phthaleins by the organic anion carrier at the sinusoidal plasma membrane level in the liver, Biochim. Biophys. Acta. 943 (1988), pp. 119–125.
   PubMed Web of Science ®Google Scholar
• M.J.S. Dewar, E.G. Zoebisch, E.F. Healy, and J.J.P. Stewart, Development and use of quantum mechanical molecular models. AM1: A new general purpose quantum mechanical molecular model, J. Am. Chem. Soc. 107 (1985), pp. 3902–3909.
   Web of Science ®Google Scholar
• A.R. Katritzky, V.S. Lobanov, and M. Karelson, Codessa 2.0, Comprehensive descriptors for structural and statistical analysis, University of Florida, USA, 1994; software available at http://www.semichem.com/codessa.
   Google Scholar
• P. Gramatica, N. Chirico, E. Papa, S. Cassani, and S. Kovarich, QSARINS: A new software for the development, analysis, and validation of QSAR MLR models, J. Comput. Chem. 34 (2013), pp. 2121–2132.
   Web of Science ®Google Scholar
• J. Zupan and J. Gasteiger, Neural Networks in Chemistry and Drug Design, Wiley-VCH, Weinheim, Germany, 1999.
   Google Scholar
• J. Zupan, M. Novic, and I. Ruisanchez, Kohonen and counterpropagation artificial neural networks in analytical chemistry, Chemometr. Intell. Lab. 38 (1997), pp. 1–23.
   Web of Science ®Google Scholar
• M. Novič and J. Zupan, Investigation of infrared spectra-structure correlation using Kohonen and counter-propagation neural network, J. Chem. Inf. Comput. Sci. 35 (1995), pp. 454–466.
   Google Scholar
• C.C. Chang and C.J. Lin, LIBSVM: A library for support vector machines, ACM TIST 2 (2011), pp. 1–27; software available at http://www.csie.ntu.edu.tw/~cjlin/libsvm.
   Google Scholar
• R. Leardi, Nature-inspired methods in chemometrics: Genetic algorithms and artificial neural networks, Elsevier, Amsterdam and Boston, 2003.
   Google Scholar
• P. Gramatica, Principles of QSAR models validation: Internal and external, QSAR Comb. Sci. 26 (2007), pp. 694–701.
   Google Scholar
• M. Vasighi and M. Kompany-Zareh, Classification ability of self organizing maps in comparison with other classification methods, MATCH Commun. Math. Comput. Chem. 70 (2013), pp. 29–44.
   Web of Science ®Google Scholar
• P. Baldi, S. Brunak, Y. Chauvin, C.A.F. Andersen, and H. Nielsen, Assessing the accuracy of prediction algorithms for classification: An overview, Bioinformatics 6 (2000), pp. 412–424.
   Web of Science ®Google Scholar
• V. Consonni, D. Ballabio, and R. Todeschini, Comments on the definition of the Q(2) parameter for QSAR validation, J. Chem. Inf. Model. 49 (2009), pp. 1669–1678.
   PubMed Web of Science ®Google Scholar
• A. Tropsha, P. Gramatica, and V.K. Gombar, The importance of being earnest: Validation is the absolute essential for successful application and interpretation of QSPR Models, QSAR Comb. Sci. 22 (2003), pp. 69–77.
   Google Scholar
• N. Minovski, Š. Župerl, V. Drgan, and M. Novič, Assessment of applicability domain for multivariate counter-propagation artificial neural network predictive models by minimum Euclidean distance space analysis: A case study, Anal. Chim. Acta. 759 (2013), pp. 28–42.
   PubMed Web of Science ®Google Scholar
• P.C.H. Hollman, M.N.C.P. Bijsman, Y. van Gameren, E.P.J. Cnossen, J.H.M. de Vries, and M.B. Katan, The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man, Free Radical Res. 31 (1999), pp. 569–573.
   PubMed Web of Science ®Google Scholar
• A. Le Roux, E. Josset, S. Benzina, B. Nadal, M.D.E. Murr, B. Heurtaux, F. Taran, J.M. Denis, T. Le Gall, S. Meunier, and P. Bischoff, Evaluation of the radioprotective potential of the polyphenol norbadione A, Lett. Drug Des. Discov. 9 (2012), pp. 48–53.
   Web of Science ®Google Scholar
• A. Saija, M. Scalese, M. Lanza, D. Marzullo, F. Bonina, and F. Castelli, Flavonoids as antioxidant agents – importance of their interaction with biomembrane, Free Radical Bio. Med. 19 (1995), pp. 481–486.
   PubMed Web of Science ®Google Scholar
• V.P. Menon and A.R. Sudheer, Antioxidant and anti-inflammatory properties of curcumin, Adv. Exp. Med. Biol. 595 (2007), pp. 105–125.
   PubMed Web of Science ®Google Scholar
• S. Biljali, V.A. Hadjimitova, M.N. Topashka-Ancheva, D.B. Momekova, T.T. Traykov, and M.H. Karaivanova, Antioxidant and antiradical properties of esculin, and its effect in a model of epirubicin-induced bone marrow toxicity, Folia Med (Plovdiv). 54 (2012), pp. 42–49.
   PubMedGoogle Scholar
• C.Y. Shaw, C.H. Chen, C.C. Hsu, C.C. Chen, and Y.C. Tsai, Antioxidant properties of scopoletin isolated from Sinomonium acutum, Phytother. Res. 17 (2003), pp. 823–825.
   PubMed Web of Science ®Google Scholar
• Y. Yilmaz and R.T. Toledo, Major flavonoids in grape seeds and skins: Antioxidant capacity of catechin, epicatechin, and gallic acid, J. Agr. Food Chem. 52 (2004), pp. 255–260.
   PubMed Web of Science ®Google Scholar
• H. Rudyk, S. Vasiljevic, R.M. Hennion, C.R. Birkett, J. Hope, and I.H. Gilbert, Screening Congo Red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells, J. Gen. Virol. 81 (2000), pp. 1155–1164.
   PubMed Web of Science ®Google Scholar
• M.L. Bolognesi, H.N.A. Tran, M. Staderini, A. Monaco, A. Lopez-Cobenas, S. Bongarzone, X. Biarnes, P. Lopez-Alvardo, N. Cabezas, M. Caramelli, P. Carloni, J.C. Menendez, and G. Legname, Discovery of a class of diketopiperazines as antiprion compounds, Chem. Med. Chem. 5 (2010), pp. 1324–1334.
   Web of Science ®Google Scholar
• M.S. Hung, Z. Xu, Y.C. Lin, J.H. Mao, C.T. Yang, P.J. Chang, D.M. Jablons, and L. You, Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library, BMC Cancer. 9 (2009), p. 135.
   PubMed Web of Science ®Google Scholar
• J.J. Hong, T.S. Jeong, J.H. Choi, J.H. Park, K.Y. Lee, Y.J. Seo, S.R. Oh, and G.T. Oh, Hematein inhibits tumor necrotic factor-alpha-induced vascular cell adhesion molecule-1 and NF-kappaB-dependent gene expression in human vascular endothelial cells, Biochem. Biophys. Res. Commun. 281 (2001), pp. 1127–1133.
   PubMed Web of Science ®Google Scholar
• J.H. Choi, T.S. Jeong, D.Y. Kim, and Y.M. Kim, H.J. Na, K.H. Nam, S.B. Lee, H.C. Kim, S.R. Oh, Y. Choi, S.H. Bok, and G.T. Oh, Hematein inhibits atherosclerosis by inhibition of reactive oxygen generation and NF-kappaB-dependent inflammatory mediators in hyperlipidemic mice, J. Cardiovasc. Pharmacol. 42 (2003), pp. 287–295.
   PubMed Web of Science ®Google Scholar
• G.T. Oh, J.H. Choi, J.J. Hong, D.Y. Kim, S.B. Lee, J.R. Kim, C.H. Lee, B.H. Hyun, S.R. Oh, S.H. Bok, and T.S. Jeong, Dietary hematein ameliorates fatty streak lesions in the rabbit by the possible mechanism of reducing VCAM-1 and MCP-1 expression, Atherosclerosis 159 (2001), pp. 17–26.
   PubMed Web of Science ®Google Scholar
• D.A. Kocisko, G.S. Baron, R. Rubenstein, J. Chen, S. Kuizon, and B. Caughey, New inhibitors of scrapie-associated prion protein formation in a library of 2.000 drugs and natural products, J. Virol. 77 (2003), pp. 10288–10294.
   PubMed Web of Science ®Google Scholar